Navigation Links
ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine

IRVINE, Calif., May 08, 2007 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc., today announced results from the preliminary analysis of its U.S. Phase II/III clinical study of bepotastine for the treatment of allergic conjunctivitis. The study evaluated two concentrations of bepotastine, each dosed once daily and twice daily. The primary endpoints of the study were the assessment of efficacy for bepotastine in treating ocular itching and redness. The preliminary results of the study demonstrate both concentrations were highly statistically significant in the reduction of the first primary endpoint, ocular itching, when dosed twice a day, and in one concentration when dosed once a day. In addition, both concentrations and dosing regimens produced highly statistically significant differences in the rapidity of response and the improvement in total nasal symptoms vs. placebo. In the preliminary evaluation of the second primary endpoint, ocular redness, bepotastine showed a trend toward clinical significance, but did not achieve statistical significance. Several ocular allergy products have been approved by the FDA based on Phase III clinical data demonstrating the achievement of statistical significance and clinical success for one of the primary endpoints, ocular itching or redness.

ISTA plans to complete the Phase II/III study analysis and then discuss the results with the Food and Drug Administration to determine the remaining clinical studies required to confirm ocular safety and efficacy for the submission of an NDA for bepotastine for the treatment of allergic conjunctivitis.

"Bepotastine's multiple mechanisms of action have the potential to provide allergy sufferers with comprehensive protection for the treatment of their ophthalmic and nasal symptoms. We are impressed with the convenient dosing schedule, the rapid onset of action, and clinical efficacy bepotastine exhibited in this study,
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA

Post Your Comments:
(Date:11/24/2009)...,, BEIJING,Nov.24/PRNewswire-Asia-FirstCall/-...("Lotus"orthe"Company")agrowingdeveloperand,produc...harmaceutical,productsinthePeople,sRepublicChina,t...mberoftheBeijingpharmaceuticaldelegation. ,, ...ConventionCenter,Chengdu ,, TheBeijingdelegat...
(Date:11/24/2009)...,, WARSAW,Ind.,Nov.24/PRNewswire-FirstCall/--...dayitwillbeparticipatinginthe21stAnnualPiperJaffra...,2009,at8:00a.m.EasternTime. ,, Alivewebcastoft...tionswebsiteat http://investor.zimmer.com .Thewebc...,, AbouttheCompany ,, Foundedin1927andhead...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Ore...armaceuticalcompanyfocusedonthetreatmentofobesity,...CommitteeoftheCompany,sBoardofDirectorsgrantedanin...stocktoPrestonKlassen,M.D.,itsnewlyappointedHeadof...tendedtobeanincentivestockoptiontotheextentpermitt...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 1Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 2Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 3Fruit fly steps in to fight human disease 12735 1Fruit fly steps in to fight human disease 12735 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 1HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 3
... how sounds are amplified in the inner ear, a find... from genetic mutation or,overdose of drugs, MEMP...spital investigators have found that an electrical...of the ear is critical to the acute,hearing of hum...tter,understanding of how hearing loss can result ...
...J., May 7 Johnson & Johnson,will provide a pre-re...ay 9,at 4:00 p.m. (Eastern Time) to coincide with ...n Tampa, Fla. Phase 3 clinical data presentations ...R), a novel centrally acting,oral analgesic, will ...corded Webcast, with the lead tapentadol researche...
Other Medicine Technology:St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 3
(Date:11/24/2009)...onLaborLifeInsuranceCompany("UnionLaborLife")annou...on,slargestvisionbenefitsandservicescompany,toprov...ustfunds,unionemployersandtheirmembers. ,, VSPh...gcomprehensiveeyeexams,broadselectionsofopticalfra...is,"statedBruceSmith,NationalSales,VSP."Comprehens...
(Date:11/24/2009)...eripheral artery disease, researchers say , ...people aged 75 and older, the herbal supplement Gi... or death, a new study finds. , There is some e...prevent the leg-circulation problem known as perip...s nutrients called flavonoids, which are also foun...
(Date:11/24/2009)... between high- and low-volume centers, study found...- Do hospitals that conduct the most angioplasties...? Maybe not. , Prior research had suggested tha...-opening procedures, but a new study involving ove...tals performing more or less equally. , The stu...
(Date:11/24/2009)...y conducted by Children,s Hospital & Research Cent...erapeutic agents found naturally in soy that can p...most deadly form of cancer. Sphingadienes (SDs) ar...ch shows may be the key to fighting colon cancer. ...scientist and director of the Cancer Center at Chi...
(Date:11/24/2009)...--TheAmericanDentalAssociation(ADA)hassignedanagre...rsaspartofapilotprogramtoimprovetheoralhealthinund...hCoordinator(CDHC)isamemberofthedentalhealthteamwh...todentalcaretoimprovetheiroralhealth. ,, TheCDH...es--includingscreeningsandfluoridetreatments.Howev...
Breaking Medicine News(10 mins):Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
...aster management , , ANAHEIM, Calif., May 4 , ..., May 17, 2009, WHERE: Anaheim Convention C... Anaheim, CA 92802, CONTACTS: Jessica Jois...nts The Art and Science of Dentistry, the, ...
...dical Insurance Strengthens Offerings to Colleges ...ore, MD. (Vocus) May 4, 2009 -- MEDEX Global Group...e acquisition of CMI Insurance, formerly a PSA com...t;We have worked hard on this deal and are very pl...
...ics Corporation (NYSE: HAE ) today reported reco...ighth consecutive quarter of double digit revenue ...et revenues of $598 million, up 16%; operating inc...ce, including continued double digit growth in ear...
...wing is a statement by Joon Yun, Director, Palo Al...from the fear of a swine flu pandemic, a panic tha.... , , Perhaps the original fear of swine flu ...ld happen again. , , Swine flu was first believe...
...e makers of Oust(R), announces that families looki... Johnson,s Oust(R) Surface Disinfectant & Air ...gainst influenza A virus. The US EPA has indicate...rks by chemically interacting with germs and virus...
...ygdala, a neural center for emotion, , , M... seem more likely to have an enlarged amygdala, a ...ions, University of North Carolina researchers rep...ification to a potential fundamental brain mechani...
Other Medicine News:Health News:Dentistry and Mass Disasters: A Dentist's Role as a First Responder During a Public Health Emergency 2Health News:Dentistry and Mass Disasters: A Dentist's Role as a First Responder During a Public Health Emergency 3Health News:MEDEX Acquires CMI Insurance 2Health News:MEDEX Acquires CMI Insurance 3Health News:Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees 2Health News:The Viral Spiral - How A Meme About the Virus May Be More Contagious Than the Virus Itself 2Health News:The Viral Spiral - How A Meme About the Virus May Be More Contagious Than the Virus Itself 3Health News:Oust(R) Surface Disinfectant & Air Sanitizer Effective Against H1N1 2Health News:Brain Anatomy Could Point to Autism 2Health News:Brain Anatomy Could Point to Autism 3
512 Lightweight Pneumatic Conserver
...e Conserver., ,Offers an average 5:1 increase in ...a standard cannula. , ,The combination of the OXY...mbulatory oxygen patients a superior alternative t...r warranty. , ,NOTE: Each model has passed th...
LOTUS™ Electronic Oxygen Conserver (with alarm)
Pfister Suture Adjustment Set For Astigmatism
Medicine Products: